Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-9.18 Insider Own9.98% Shs Outstand10.10M Perf Week11.38%
Market Cap5.73M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.09M Perf Month15.27%
Income-22.23M PEG- EPS next Q- Inst Own2.44% Short Float / Ratio1.02% / 0.08 Perf Quarter-28.23%
Sales3.62M P/S1.58 EPS this Y- Inst Trans-0.59% Short Interest0.09M Perf Half Y-72.57%
Book/sh-0.52 P/B- EPS next Y- ROA-200.59% Target Price105.00 Perf Year-95.94%
Cash/sh0.66 P/C0.86 EPS next 5Y- ROE-784.96% 52W Range0.45 - 21.70 Perf YTD-95.21%
Dividend- P/FCF- EPS past 5Y27.79% ROI- 52W High-97.38% Beta1.20
Dividend %- Quick Ratio0.54 Sales past 5Y13.88% Gross Margin-52.56% 52W Low26.02% ATR0.05
Employees11 Current Ratio0.58 Sales Q/Q-99.40% Oper. Margin-519.35% RSI (14)54.86 Volatility10.02% 7.92%
OptionableNo Debt/Eq- EPS Q/Q90.43% Profit Margin-614.21% Rel Volume0.10 Prev Close0.54
ShortableYes LT Debt/Eq- EarningsNov 14 BMO Payout- Avg Volume1.23M Price0.57
Recom3.00 SMA2010.60% SMA501.80% SMA200-84.90% Volume125,040 Change4.76%
Date Action Analyst Rating Change Price Target Change
May-13-20Upgrade Maxim Group Hold → Buy $1.50
Feb-27-20Downgrade Dawson James Buy → Neutral
Nov-26-19Downgrade Raymond James Outperform → Mkt Perform
Jul-16-19Downgrade B. Riley FBR Neutral → Sell $1.90 → $1.10
Nov-12-18Downgrade B. Riley FBR Buy → Neutral $7.50 → $2.50
May-11-18Reiterated Maxim Group Buy $5 → $10
Mar-23-18Reiterated B. Riley FBR, Inc. Buy $6.25 → $7.50
Dec-05-17Reiterated Maxim Group Buy $13 → $14
Oct-04-17Resumed B. Riley & Co. Buy $9.50
Jul-21-16Reiterated Maxim Group Buy $17 → $10
Nov-28-23 08:05AM
Nov-14-23 07:30AM
Nov-13-23 10:52AM
Oct-30-23 07:30AM
Oct-20-23 04:15PM
04:05PM Loading…
Oct-19-23 04:05PM
Sep-07-23 12:00PM
Aug-21-23 09:21AM
Aug-04-23 01:43PM
Aug-02-23 08:30AM
Jul-28-23 08:30AM
Jun-26-23 07:30AM
Jun-22-23 07:30AM
May-25-23 04:26PM
12:00PM Loading…
May-19-23 12:00PM
May-16-23 06:26AM
May-15-23 04:47PM
May-08-23 04:05PM
Mar-19-23 10:33PM
Mar-17-23 08:40AM
Mar-16-23 04:24PM
Mar-14-23 04:01PM
Feb-28-23 08:22AM
Feb-27-23 04:05PM
Feb-22-23 04:01PM
Dec-29-22 06:02AM
Nov-14-22 04:10PM
04:05PM Loading…
Nov-07-22 04:05PM
Oct-04-22 06:27AM
Oct-03-22 04:30PM
Sep-21-22 09:58AM
Sep-12-22 04:05PM
Aug-12-22 05:00PM
Aug-10-22 04:02PM
Aug-08-22 07:30AM
Jul-29-22 08:00AM
Jul-21-22 07:30AM
Jun-01-22 08:00AM
May-31-22 12:00PM
May-26-22 04:05PM
May-18-22 05:00PM
May-16-22 04:35PM
May-09-22 05:56PM
Mar-31-22 04:49PM
Mar-30-22 05:15PM
Mar-29-22 08:15PM
Mar-28-22 05:25PM
Mar-24-22 07:30AM
Mar-22-22 07:30AM
Mar-21-22 04:05PM
Mar-14-22 08:17AM
Mar-04-22 07:30AM
Feb-28-22 07:30AM
Feb-18-22 04:05PM
Feb-07-22 09:17AM
Jan-10-22 07:30AM
Dec-20-21 10:00AM
Dec-01-21 07:30AM
Nov-23-21 02:39PM
Nov-22-21 04:47PM
Nov-19-21 03:34PM
Oct-18-21 08:55AM
Oct-11-21 05:44PM
Oct-04-21 07:30AM
Sep-03-21 12:12PM
Sep-02-21 10:56AM
Aug-24-21 04:05PM
Aug-19-21 07:30AM
Aug-04-21 04:05PM
Jul-19-21 04:05PM
Jul-13-21 08:00AM
Jul-01-21 08:00AM
Jun-28-21 07:00AM
Jun-18-21 08:32AM
Jun-14-21 09:00AM
Jun-13-21 02:11PM
Jun-11-21 07:30AM
Jun-09-21 07:30AM
Jun-07-21 09:51AM
Jun-01-21 07:30AM
May-28-21 04:04PM
May-26-21 03:00PM
May-25-21 07:42PM
May-17-21 04:05PM
DMK Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.